Abstract
Background
Appendiceal tumors are rare, and their pathogenesis is not well known. DNA damage response (DDR) is a sequence from the detection of damaged DNA to the repair, and its impairment is implicated in the progression of cancers. The aim of the current study is to explore the expression and phosphorylation of checkpoint kinase 2 (Chk2) and TP53, which are key molecules in DDR, and their clinicopathological correlation in the appendiceal tumors.
Methods
Chk2, phosphorylated Chk2 (pChk2), and TP53 were immunostained in 4 cases of adenoma (AD), 5 non-mucinous adenocarcinomas (AC), 29 low-grade appendiceal mucinous neoplasms (LAMN), and 7 mucinous adenocarcinomas (MAC). Ki-67 labeling index was also evaluated by immunostaining.
Results
Chk2 was highly expressed in the nuclei of all the appendiceal tumors. While pChk2 was high in AD, LAMN, and MAC, it was reduced in AC. Nuclear positive reaction of TP53 was lower in LAMN compared with those of other tumors. The Ki-67 labeling index was slightly lower in LAMN than those in other tumors. The recurrence and death in LAMN is infrequent compared with those in AC and MAC.
Conclusions
The current study suggested the impairment of DDR in AC and MAC. DDR appeared to be preserved in LAMN, and it may account for low proliferating activity and a favorable clinical course in LAMN.
Similar content being viewed by others
References
Carr NJ, Sobin LH (2010) Adenocarcinoma of the appendix. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO classification of tumours of the digestive system. International Agency for Research on Cancer, Lyon, pp 122–125
Misdraji J, Yantiss RK, Graeme-Cook FM, Balis UJ, Young RH (2003) Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 27(8):1089–1103
Jackson SP, Bartek J (2009) The DNA-damage response in human biology and disease. Nature 461(7267):1071–1078
Harper JW, Elledge SJ (2007) The DNA damage response: ten years after. Mol Cell 28(5):739–745
Oka K, Tanaka T, Enoki T, Yoshimura K, Ohshima M, Kubo M, Murakami T, Gondou T, Minami Y, Takemoto Y, Harada E, Tsushimi T, Li TS, Traganos F, Darzynkiewicz Z, Hamano K (2010) DNA damage signaling is activated during cancer progression in human colorectal carcinoma. Cancer Biol Ther 9(3):246–252
Takabayashi H, Wakai T, Ajioka Y, Korita PV, Yamaguchi N (2013) Alteration of the DNA damage response in colorectal tumor progression. Hum Pathol 44(6):1038–1046
Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Orntoft T, Lukas J, Bartek J (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434(7035):864–870
Halazonetis TD, Gorgoulis VG, Bartek J (2008) An oncogene-induced DNA damage model for cancer development. Science 319(5868):1352–1355
Poehlmann A, Roessner A (2010) Importance of DNA damage checkpoints in the pathogenesis of human cancers. Pathol Res Pract 206(9):591–601
Yajima N, Wada R, Yamagishi S, Mizukami H, Itabashi C, Yagihashi S (2005) Immunohistochemical expressions of cytokeratins, mucin core proteins, p53, and neuroendocrine cell markers in epithelial neoplasm of appendix. Hum Pathol 36(11):1217–1225
Taggart MW, Galbincea J, Mansfield PF, Fournier KF, Royal RE, Overman MJ, Rashid A, Abraham SC (2013) High-level microsatellite instability in appendiceal carcinomas. Am J Surg Pathol 37(8):1192–1200
Misdraji J, Burgart LJ, Lauwers GY (2004) Defective mismatch repair in the pathogenesis of low-grade appendiceal mucinous neoplasms and adenocarcinomas. Mod Pathol 17(12):1447–1454
Rossi G, Bertolini F, Sartori G, Bigiani N, Cavazza A, Foroni M, Valli R, Rindi G, De Gaetani C, Luppi G (2004) Primary mixed adenocarcinoma and small cell carcinoma of the appendix: a clinicopathologic, immunohistochemical, and molecular study of a hitherto unreported tumor. Am J Surg Pathol 28(9):1233–1239
Yantiss RK, Panczykowski A, Misdraji J, Hahn HP, Odze RD, Rennert H, Chen YT (2007) A comprehensive study of nondysplastic and dysplastic serrated polyps of the vermiform appendix. Am J Surg Pathol 31(11):1742–1753
Komm M, Kronawitter-Fesl M, Kremer M, Lutz L, Holinski-Feder E, Kopp R (2011) Primary mucinous adenocarcinoma of the vermiform appendix with high grade microsatellite instability. J Cancer Educ 2:302–306
Karamurzin Y, Zeng Z, Stadler ZK, Zhang L, Ouansafi I, Al-Ahmadie HA, Sempoux C, Saltz LB, Soslow RA, O’Reilly EM, Paty PB, Coit DG, Shia J, Klimstra DS (2012) Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature. Hum Pathol 43(10):1677–1687
Cunningham JM, Kim CY, Christensen ER, Tester DJ, Parc Y, Burgart LJ, Halling KC, McDonnell SK, Schaid DJ, Walsh Vockley C, Kubly V, Nelson H, Michels VV, Thibodeau SN (2001) The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 69(4):780–790
Zauber P, Berman E, Marotta S, Sabbath-Solitare M, Bishop T (2011) Ki-ras gene mutations are invariably present in low-grade mucinous tumors of the vermiform appendix. Scand J Gastroenterol 46(7–8):869–874
Acknowledgments
The authors feel grateful to Dr. Mitsuomi Kaimori, Dr. Yosei Katayama, Dr. Hidekachi Kurotaki, and Dr. Yoshihito Ebina for their constructive suggestions. This study is supported by Hirosaki University Grant for Exploratory Research by Young Scientists.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yajima, N., Wada, R., Matsuzaki, Y. et al. DNA damage response and its clinicopathological relationship in appendiceal tumors. Int J Colorectal Dis 29, 1349–1354 (2014). https://doi.org/10.1007/s00384-014-1996-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-014-1996-6